4//SEC Filing
Heyman Irwin A 4
Accession 0001104659-12-018269
CIK 0001411158other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:35 PM ET
Size
5.3 KB
Accession
0001104659-12-018269
Insider Transaction Report
Form 4
Heyman Irwin A
Senior VP Product Development
Transactions
- Award
Stock Option (right to buy)
2012-03-13+40,000→ 40,000 totalExercise: $5.59Exp: 2022-03-12→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the option shall vest and become exercisable on the twelve-month anniversary of the Vesting Commencement Date (1/1/2012) and 1/48 of the shares subject to the option shall vest and become exercisable each month thereafter.
Documents
Issuer
Anacor Pharmaceuticals Inc
CIK 0001411158
Entity typeother
Related Parties
1- filerCIK 0001504369
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:35 PM ET
- Size
- 5.3 KB